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a b s t r a c t
Objective: To develop an innovative and effective educational intervention to inform patients about the
need for osteoporosis treatment and to determine factors associated with its online uptake.
Methods: Postmenopausal women with a prior fracture and not currently using osteoporosis therapy
were eligible to be included in the Activating Patients at Risk for OsteoPOroSis (APROPOS). Four nominal
groups with a total of 18 racially/ethnically diverse women identiﬁed osteoporosis treatment barriers.
We used the Information, Motivation, Behavior Skills conceptual model to develop a direct-to-patient
intervention to mitigate potentially modiﬁable barriers to osteoporosis therapy. The intervention
included videos tailored by participants’ race/ethnicity and their survey responses: ranked barriers to
osteoporosis treatment, deduced barriers to treatment, readiness to behavior change, and osteoporosis
treatment history. Videos consisted of “storytelling” narratives, based on osteoporosis patient experi-
ences and portrayed by actresses of patient-identiﬁed race/ethnicity. We also delivered personalized
brief phone calls followed by an interactive voice-response phone messages aimed to promote uptake of
the videos.
Abbreviations: BMD, bone mineral density; GI, gastrointestinal; GLOW, Global Longitudinal Study of Osteoporosis in Women; HIV, human immunodeﬁciency virus; IMB,
information, motivation, behavior; IVR, interactive voice-response; NG, nominal group; NHANES, National Health and Nutrition Examination Study; PAM, Patient Activation
Measure; PAPM, Precaution Adoption Process Model; ONJ, osteonecrosis of the jaw.
* Corresponding author. Department of Medicine, Division of Immunology and Rheumatology, FOT 820, 510 20th Street South, University of Alabama at Birmingham,
Birmingham, AL 35294, USA.
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Results: To address the factors associated with online intervention uptake, we focused on participants
assigned to the intervention arm (n ¼ 1342). These participants were 92.9% Caucasian, with a mean (SD)
age 74.9 (8.0) years and the majority (77.7%) had some college education. Preference for natural treat-
ments was the barrier ranked #1 by most (n ¼ 130; 27%), while concern about osteonecrosis of the jaw
was the most frequently reported barrier (at any level; n ¼ 322; 67%). Overall, 28.1% (n ¼ 377) of par-
ticipants in the intervention group accessed the videos online. After adjusting for relevant covariates, the
participants who provided an email address had 6.07 (95% CI 4.53e8.14) higher adjusted odds of
accessing their online videos compared to those who did not.
Conclusion: We developed and implemented a novel tailored multi-modal intervention to improve
initiation of osteoporosis therapy. An email address provided on the survey was the most important
factor independently associated with accessing the intervention online. The design and uptake of this
intervention may have implications for future studies in osteoporosis or other chronic diseases.
© 2016 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Osteoporosis contributes to more than 2 million fractures each
year in the United States (U.S.) and is responsible for $19 billion
costs annually [1]. Despite robust evidence supporting national
guidelines for various medications to signiﬁcantly reduce fracture
risk among persons with prior fractures [2e7], only about 1 in 5
older womenwith a prior fracture receives osteoporosis evaluation
and fewer than half of these women receive a prescription for
osteoporosis therapy [8]. Even after receiving a prescription, only
60e70% of patients initiate osteoporosis treatment [9,10]. There is
an urgent need for interventions aimed at increasing osteoporosis
therapy initiation for patients at high fracture risk.
The majority of interventions used to improve uptake of oste-
oporosis treatment have targeted health care providers rather
than patients [11e18]. The sparsity of patient activation in-
terventions in the osteoporosis ﬁeld is surprising given the re-
ported successes of these methods in improving outcomes
including improved patient knowledge [19e21], calcium intake
[22], physical activity [23], and bone mineral density (BMD)
testing [24]. Given the major societal trend for increased patient
involvement in shared decision making [25,26], patient-based
interventions are often more pragmatic and cost effective than
more traditional provider-based interventions, though evidence of
effectiveness is largely lacking [27].
From the patient perspective, the causes of non-initiation of
osteoporosis therapy include concerns about medication side ef-
fects, costs, polypharmacy, and perceptions of limited efﬁcacy
[10,28e31]. According to the Information, Motivation and Behav-
ioral Skills model (IMB) [32], when people are well-informed,
motivated to act, and possess the skills and conﬁdence to take ac-
tion, they aremore likely to initiate andmaintain health-promoting
behaviors that produce positive outcomes. The IMBmodel has been
applied successfully to a variety of health behaviors, including
changing risk behavior [32] and adherence to medications [33,34]
for human immunodeﬁciency virus/acquired immunodeﬁciency
syndrome and breast self-examination [35].
Internet-based communication technologies, with their advan-
tageous cost effectiveness and ability to efﬁciently reach a large
number of people [36], can help address the existing gap between
guidelines and clinical practice for chronic conditions, such as
osteoporosis. Online interventions can be tailored, are readily
scalable and convenient, and are easily accessible to those with
internet access, thus making them ideal venues for delivery of self-
care and behavior-change programs for a large and rapidly growing
segment of society that includes older adults [37]. This manuscript
details formative qualitativework and the development and uptake
of our online-delivered, individually-tailored, video-based, and
multi-modal intervention within an ongoing cohort study of oste-
oporosis in older women.
2. Methods
We used the IMB model conceptual framework to develop a
direct-to-patient, tailored intervention aimed at increasing the
initiation of osteoporosis medications in women at high risk for
fractures. We used qualitative methods to elicit information,
motivation, and behavioral skills important to initiating osteopo-
rosis treatment. Next, we designed a video-based, individually-
tailored intervention to help mitigate potentially modiﬁable bar-
riers to osteoporosis therapy. The interventionwas delivered online
and by DVD mailings to women aged 55 and older who had a
history of fractures. We also conducted personalized phone calls
followed by interactive voice-response (IVR) messages to promote
intervention uptake.
2.1. Study population
The Global Longitudinal Study of Osteoporosis in Women
(GLOW) cohort is an international prospective, longitudinal,
observational study of women 55 years of age and older. Data on
osteoporosis risk factors, treatment approaches, patient attitudes,
beliefs and behaviors related to osteoporosis, and fracture out-
comes have been collected for up to 5 years through annual patient
questionnaires from 2005 to 2011. GLOW includes 60,393 women
(28,170 in the US) recruited from 723 physicians (298 in the US)
[38]. We sent survey materials to the subset of GLOW participants
from the 7 GLOW U.S. sites (Birmingham, AL; Los Angeles, CA;
Worcester, MA; New York, NY; Cincinnati, OH; Pittsburgh, PA;
Seattle, WA) at high risk for future fracture as determined by: (1)
reported history of a prior fracture after age 45 in previous GLOW
surveys, and (2) no reported current use of osteoporosis medication
with the exception of estrogen treatments. This sub-cohort of
GLOW participants (n ¼ 2684) formed the Activating Patients at
Risk for OsteoPOroSis (APROPOS) study population. The APROPOS
baseline survey was sent to 4928 GLOW participants who had a
fracture history. We received 3226 completed surveys (64%
response rate), of which 2684 met eligibility criteria. These women
were randomized to receive intervention materials (intervention
group, n¼ 1342) or usual care (no intervention and routinemedical
care per their existing health care providers, n ¼ 1342). The inter-
vention was developed as part of a randomized clinical trial
(ClinicalTrials.gov identiﬁer NCT01907269) and was provided free
of charge to participants. This report focuses on the intervention
development and factors associated with the uptake of our online
intervention.
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2.2. Intervention development (Fig. 1)
2.2.1. Identiﬁcation and assessment of barriers to osteoporosis
treatment (Fig. 1a)
Potential barriers to osteoporosis treatment were identiﬁed and
prioritized using a nominal group (NG) technique, which allowed
participation from all group members, and promoted group-
decision making [39]. We conducted 4 nominal groups (2 each in
Birmingham, AL and Los Angeles, CA) with ethnically and racially
diverse postmenopausal women with an overall history of osteo-
porotic fracture not currently receiving osteoporosis treatment
(total n ¼ 18). Two groups had never received medication and
women within the other two groups had started medication but
stopped. We asked each woman to individually identify barriers to
osteoporosis medication use. Each group generated a list of barriers
and, subsequently, each participant voted on her top 3 barriers. This
resulted in a rank ordered list of 29 potential barriers to osteopo-
rosis treatment. We combined responses with similar wording/
meaning, thereby reducing the list to 25 (Appendix A). We
reviewed and grouped barriers by common themes (e.g., prefer-
ences for dietary supplements rather than prescription medica-
tions, etc.) and identiﬁed those that could potentially be mitigated
by a video-based intervention. For example, we obtained investi-
gator group consensus that information and patient testimonials
provided by a video could potentially address participants’ con-
cerns about osteonecrosis of the jaw (ONJ), but would be less suc-
cessful in addressing barriers related to medication costs. This
procedure generated a list of seven potentially modiﬁable barriers.
2.2.2. Baseline survey development
Based on prior GLOW surveys [40], we created a survey to assess
health history, use of osteoporosis prescriptionmedication, fracture
history, use of dietary supplements, perceived ability to commu-
nicate with a health care provider about bone health [41], health
literacy [42], preferences for sources of health information, modi-
ﬁed patient activation measure (PAM) [43], as well as items from
the Patients’ views about osteoporosis and use of therapy scale [10].
We also assessed readiness to behavior change using a modiﬁed
form of the Weinstein Precaution Adoption Process Model (PAPM)
[44]. We deﬁned pre-contemplative participants, representing the
individuals in the unaware and unengaged stages of PAPM, as those
that had no intent of initiating prescription treatment for osteo-
porosis. Contemplative participants, representing those in the un-
decided, decided not to act, and decided to act stages of PAPM, were
deﬁned as actively considering initiating prescription treatment for
osteoporosis [45].
Guided by potentially modiﬁable barriers identiﬁed from the
NGs, we surveyed all randomized APROPOS study participants
(n ¼ 2684) and asked them to rank up to three of the eight
potentially modiﬁable barriers to osteoporosis treatment We
mailed this survey to eligible women enrolled in the GLOW US
cohort, aged 55 and older and with self-reported history of fracture.
2.2.3. Video development and content
We next developed an individualized direct-to-patient, video-
based intervention grounded in narrative communication (“story-
telling”) [46,47] that consisted of video segments to address the
barriers ranked by participants. First, we used the constructs of the
IMB model [48] to frame each potentially modiﬁable barrier. Then,
we developed an outline for video materials including the barrier/
treatment concern, how to overcome the problem, and whether a
patient actor, health care professional, or both would be featured
addressing the problem. Additional outlines were developed for
general osteoporosis risk awareness and communication of bone
health issues with health care providers.
Using the outlines as a guide, we performed structured in-
terviews with osteoporosis patients (n ¼ 8) receiving care at the
University of Alabama at Birmingham. The interviews captured
each patient’s experiences with her bone health including: con-
cerns about starting and taking prescription medication; concerns
about fractures and their impact on daily life; and skills used for
talking with their health care team about improving bone health.
We reviewed and divided interview transcripts into discrete story
units focused on a single message to create scripts for the videos.
When needed, parts from multiple patients’ interviews were
combined to deliver a single coherent message addressing a spe-
ciﬁc barrier to osteoporosis treatment. If the structured patient
interviews did not provide sufﬁcient information to address one
barrier, a script for a health care provider actor was created and
used in the video. The role of the health care provider scripts was to
reinforce and supplement patient stories.
2.2.4. Tailoring of the intervention
We tailored our intervention based on (1) the survey responses
and (2) participant’s reported race/ethnicity. For the ﬁrst layer of
intervention tailoring, four mutually exclusive groups received
tailored video assignments based on their survey responses: Group
I: individuals who ranked or identiﬁed barriers to osteoporosis
treatment, Group II: individuals who did not rank barriers, but
where barriers could be deduced based on responses to survey
materials (i.e. physician recommended break from osteoporosis
medications, more than 5 years of treatment, concerns about long-
term adverse events as assessed by the Patients’ Views about
Osteoporosis and Use of Therapy scale [10]), Group III: individuals
who did not identify barriers to treatment but for whom readiness
to behavior change using a modiﬁed form of Weinstein PAPM was
available, Group IV: Individuals for whom only the osteoporosis
treatment history was available and who did not provide answers
to the survey items on barriers to osteoporosis treatment or read-
iness to behavior change.
Those participants who did not rank barriers or identify other
reasons for not taking osteoporosis medications on our survey
(Group III) received videos tailored to their level of readiness for
behavior change based on their responses to items in theWeinstein
PAPM [44,45]. To determine the most appropriate video materials
to provide these participants, we pilot tested a series of general
osteoporosis knowledge videos with pre-contemplative (n¼ 6) and
contemplative (n ¼ 6) women in Los Angeles, CA and Birmingham,
AL. These videos focused on osteoporosis risk awareness, impact of
a fracture on others, general concerns about medications, available
treatment options, and the rationale behind why dietary supple-
ments alone are not enough for bone health. Using a 5-point Likert
scale with 1 indicating very unlikely and 5 indicating very likely, we
asked the pilot test participants to rate each video on its ability to
promote behavior change (e.g., “video made me want to talk to my
health care provider about my bone health” and “video made me
want to start a medicine for my bones”) and provided the videos
with the highest rankings for pre-contemplative and contemplative
women who received the intervention materials.
For the second layer of tailoring, we produced video segments
with patients of the same ethnicity/race as self-identiﬁed by the
participants (e.g., patient actors from the same racial (Caucasian
and African American) and ethnic (Hispanic and non-Hispanic)
backgrounds). For the patient scripts, we recorded ﬁve standard-
ized patient actresses (2 Caucasian, 2 African American, 1 Hispanic
American) and for health care provider script, one Caucasian, fe-
male nurse educator. We assigned a Hispanic American actress to
participants who self-identiﬁed as being of Hispanic/Latino origin
or descent regardless of whether they later indicated they were
Caucasian, African American, or other. Participants who self-
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identiﬁed their race as Asian or other (<2% of our intervention
population), received videos with a Caucasian actress.
2.2.5. Video intervention content development
The video intervention (see Fig. 1b) had 3 components. The ﬁrst
component included an introduction video explaining why the
participant was receiving the material. The second component
included either: 2a) up to 3 three barrier-speciﬁc videos (for par-
ticipants who reported  3 barriers) or videos addressing the most
commonly reported and highest ranked barriers (for the participants
that ranked  4 barriers), or 2b) up to two videos focused on oste-
oporosis (for those who did not rank barriers). The third component
included a video on “how to talk to your doctor” communication
techniques that patients could use to discuss osteoporosis treatment
with their health care professional for all participants [49].
To maximize the relevance of the video program to individual
participants and ensure that participants were not overwhelmed by
the extent/length of the educational materials received, the inter-
vention was customized to address their 3 highest ranked barriers
reported on baseline surveys by combining multiple video seg-
ments into a single video. Importantly, the survey did not formally
restrict participants to selecting only 3 barriers, nor to ranking
identiﬁed barriers as the top 3 (i.e. a participant could identify 3
barriers and rank these all as #1). In those instances where par-
ticipants did not clearly rank barriers as instructed, we adhered to
the rankings as closely as possible for selecting the intervention
materials.
Participants assigned to Group III intervention materials (i.e.
those who did not rank barriers to osteoporosis treatment and for
whom other reasons for not taking osteoporosis medications were
not available) were provided with videos based on their answers to
the modiﬁed form of the Weinstein PAPM. Contemplative partici-
pants were provided videos on ‘treatment options” and “supple-
ments are not enough”, while the pre-contemplative participants
were provided videos on “osteoporosis risk awareness”.
Finally, participants who failed to identify any barriers to
treatment and for whomwe were unable to determine the level of
readiness to behavior change (Group IV) were assigned videos on
“osteoporosis treatment options” and “supplements are not enough” if
they indicated prior osteoporosis treatment or a general “osteopo-
rosis risk awareness” video if they had not reported prior osteopo-
rosis treatment.
The contractor cost for intervention development (video and
DVD production, website development, and internet domain) was
$68,036. This estimate excludes ongoing maintenance cost of the
intervention or investigator and staff costs and time devoted to the
development and implementation of the intervention which were
supported by a 5-year NIH grant, making it difﬁcult to assign cost to
these items.
2.3. Intervention delivery/implementation (Fig. 2)
We delivered the video intervention free of charge to partici-
pants in the intervention arm online and through DVDmailings. For
participants in the intervention arm, we initially mailed an intro-
ductory letter containing an overview of the video program, in-
structions for accessing the materials, a web link, and a code that
enabled participants to access their personalized video program
online. An email with content similar to the introductory letter was
sent to all participants who provided an email address on the
Fig. 1. Intervention design for women in the Activating Patients at Risk for OsteoPOroSis (APROPOS) Study. (a) Nominal groups were used to generate a list of barriers
(Appendix A) that experts reduced to those potentially modiﬁable by an intervention. Potentially modiﬁable barriers were ranked by participants on surveys and these responses
were used to tailor the ﬁrst layer of the intervention, followed by the second layer of tailoring (self-identiﬁed race/ethnicity) (b). Participants received video segments with three
components: an introduction, videos tailored based on participant ranked speciﬁc barriers or general osteoporosis treatment barriers, and a video on “How to talk to your doctor”
communication techniques *Women who self-identiﬁed other than Caucasian, African American, and/or Hispanic comprised less than 2% of our intervention population and
received intervention videos with Caucasian female educators and patient actresses.
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baseline survey 2e3 days after the introductory letter. The email
contained a hyperlink directing the participant to her personalized
video program. As part of the personalized video intervention, we
also included a “Talking Points Card” containing a set of questions
about bone health that the participants were encouraged to discuss
with their health care provider. Approximately one week after the
initial letter and email (if applicable) were sent, we mailed partic-
ipants in the intervention arm a DVD with their personalized video
program (and a DVD player for those who did not report having
one), a second copy of the introduction letter, and a hard copy of the
“Talking Points Card”.
One week later, a project staff member called the study partic-
ipants who were sent the intervention materials and who had
provided phone numbers (termed a “warm handoff’), but who had
not viewed videos online. The goal of this phone call was to further
introduce the video program intervention thereby increasing
participant engagement. During this warm handoff call, we
informed participants of the reason for the intervention materials,
Fig. 2. Intervention deployment workﬂow for women in the Activating Patients at Risk for OsteoPOroSis (APROPOS) Study. IVR, interactive voice-response.
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attempted to identify and address any barriers to watching the
videos (e.g., sending a DVD player), and conﬁrmed or requested an
email address. Participants who provided an email during the
warm handoff call were subsequently sent an email with the web
link and code to access their personalized video program.
Approximately 1e2 weeks after the warm handoff phone call, we
used interactive voice response (IVR) technology to deliver an
automated phone call to the participants in the intervention arm
who had not yet viewed the videos online for the purpose of
inquiring whether the materials had been viewed and if they had
experienced barriers to watching the videos.
Approximately 4 weeks after the introductory letter, partici-
pants who could not be contacted by phone or who had not pro-
vided a telephone number on the baseline survey, or who had not
viewed the website were mailed a reminder package. This package
contained a copy of the introductory letter detailing the in-
structions on how to access the video program online, and included
the web address linked to the personalized code-accessed video
program, as well as another DVD with the individualized video
intervention.
2.4. Statistical analysis overview
We used descriptive statistics to characterize the population
recruited to the intervention arm. Means (SD) were calculated for
normally distributed continuous variables and proportions were
used to describe categorical variables. For this descriptive study,
primary dependent variable was deﬁned as uptake of the inter-
vention and was operationalized by assessing participants’ suc-
cessfully logging onto their own personal website within 60 days
after initial contact by email. We chose this time cut point as a
pragmatic data lock for our intervention uptake because during this
timeframe more than 95% of the individuals had logged onto their
personalized website. The proportion of participants logging on to
the website was reported overall by sociodemographic subgroups
as well as by type of contact provided (e.g., email only, phone only,
phone and email, and no email/no phone). Bivariate tests (e.g.,
student t tests and chi square tests) and stepwise multivariable
logistic regression were used to evaluate differences in uptake of
the intervention by sociodemographic characteristics and type of
contact. The following covariates were considered in the multi-
variable analyses: age, race/ethnicity, education, study site, health
literacy, self-reported history of depression, readiness to behavior
change, and whether the participants expressed concerns about
osteoporosis. We report both unadjusted and adjusted odds ratios
(ORs/aORs), respectively, and corresponding 95% conﬁdence in-
tervals (CIs) to express the strength of the association between
having an email address and interacting with the website. For
stepwise regression analyses, we entered variables of interest into
the model if the p values were less than 0.1 and retained in the ﬁnal
model only signiﬁcant variables with p values less than 0.05 or
those variables considered biologically important. All analyses
were conducted using SAS v9.3 (Enterprise Guide v4.3) package.
3. Results
To address the factors associated with online intervention up-
take, we focused our analysis on participants assigned to the
intervention arm (n ¼ 1342). Observational data for our population
was normally distributed as measured with Quantile-Quantile
plots. These participants were 92.9% Caucasian, with a mean (SD)
age of 74.9 (8.0) years and the majority (77.7%) had some college
education. Overall, 28% (377 out of 1342) of women randomized to
receive the intervention videos logged on to the educational ma-
terials online within 60 days after the initial mailing of the
intervention materials (Table 1). Demographic characteristics of
women randomized to the intervention arm, stratiﬁed by whether
or not they interacted with the video intervention materials are
presented in Table 1. Of the women randomized to the intervention
arm, 860 did not rank any barriers to osteoporosis treatment
(64.1%), 364 ranked 3 or fewer barriers (27.1%), and 118 ranked 4 or
more barriers (8.8%) (Table 2). Preference for “natural treatments”
was ranked highest by 130 women on the baseline survey, while
ONJ was the most frequently endorsed barrier overall (n ¼ 322).
A total of 1342 women were mailed the introductory letter and
intervention materials via email and standard mail. The interven-
tionwas tailored based on the participants’ responses to the survey
assessing their barriers to osteoporosis treatment as presented in
Fig. 3. To encourage the uptake of the intervention, study team
personnel conducted 876 phone calls (warm handoffs) to the par-
ticipants who provided phone numbers. A total of 544 of these calls
were answered for a contact rate of 62.1%. Out of the 862 calls
attempted by the IVR system, there were 400 successful calls, for a
contact rate of 46.4%.
The proportion of women who accessed the intervention web-
site within 60 days after the initial email contact was signiﬁcantly
Table 1
Demographic characteristics of respondents (N ¼ 1342) randomized to the inter-
vention, divided by website activity.a
Logged onto website within 60 days
Yes No p-value
n ¼ 377 n ¼ 965
Age, mean (SD), years 72.9(7.0) 75.7(8.2) <0.0001
Age1
60e69 132(35.0%) 248(25.7%) <0.0001
70e79 172(45.6%) 393(40.7%)
80e89 68(18.0%) 281(29.1%)
90þ 5(1.3%) 43(4.5%)
Race/ethnicity
Caucasian 363(96.3%) 884(91.6%) 0.0027
Other 14(3.7%) 81(8.4%)
Recruitment site
Birmingham, AL 44(11.7%) 162(16.8%) 0.017
Cincinnati, OH 35(9.3%) 110(11.4%)
Los Angeles, CA 46(12.2%) 79(8.2%)
New York, NY 52(13.8%) 115(11.9%)
Pittsburgh, PA 55(14.6%) 141(14.6%)
Seattle, WA 82(21.8%) 167(17.3%)
Worcester, MA 63(16.7%) 191(19.8%)
Education2
Some high school or less 3(0.8%) 37(3.9%) <0.0001
High school graduate 41(11.0%) 214(22.5%)
Some college or more 329(88.2%) 701(73.6%)
Concerned about osteoporosis3 215(61.6%) 495(57.3%) 0.1511
No past treatment for osteoporosis4 105(28.5%) 344(38.0%) 0.0013
Comorbidities
Depression5 70(19.4%) 202(21.9%) 0.3411
Readiness to behavior changeb, 6
Pre-contemplative 239(74.2%) 583(75.3%) 0.7018
Contemplative 83(25.8%) 191(24.7%)
Phone/email provided
Phone and email 219(58.1%) 253(26.2%) <0.0001
Email only 77(20.4%) 92(9.5%)
Phone only 53(14.1%) 374(38.8%)
Neither 28(7.4%) 246(25.5%)
Health literacy
Adequate 350(94.1%) 794(84.8%) <0.0001
Inadequate 22(5.9%) 142(15.2%)
1missing for 2 persons, 2missing for 17, 3missing for 130, 4missing for 67, 5missing
for 58, 6missing for 246.
a For categorical variables data is presented as N(%).
b readiness to behavior change assessed with a modiﬁed form of the Weinstein
Precaution Adoption Process Model (PAPM).
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greater (46.2%; 296 out of 641) among the participants who pro-
vided an email address compared to those who did not provide an
email address, (11.6%; 81 out of 701) (p < 0.0001) (Fig. 4). Compared
to the womenwho did not logon to view the intervention materials
within the 60 day period, women who logged on to their person-
alized website were more likely to have provided an email address
(aOR ¼ 6.07, 95% CI 4.53e8.14), and less likely to self-report
depression (aOR 0.72, 95% CI 0.51e0.996) (Table 3). In addition,
there was an 18% lower odds of accessing the videos for every ten
years of advancing age (aOR ¼ 0.82, 95% CI 0.66e0.95). Individuals
who interactedwith thewarm handoff or the IVR component of the
intervention were less likely to logon to the intervention website
compared to those who were not exposed to the warm handoff or
IVR components of the intervention.
4. Discussion
We designed a multi-modal intervention for women at high risk
of fracture tailored to barriers or concerns about osteoporosis
treatment, readiness to behavior change, osteoporosis treatment
history, and race/ethnicity. This intervention employed print and
audiovisual components, and was delivered via internet and mail.
We further encouraged interaction with our material by delivering
DVDs, personalized reminder phone calls, and IVR calls. Approxi-
mately a quarter of women interacted with their personalized
website, and among those who provided email addresses, 46.2%
Table 2
Seven osteoporosis treatment barriers identiﬁed and ranked by survey respondents.
Barrier Ranked#1 Ranked#2 Ranked#3 Cumulativea
Osteonecrosis of the jaw concerns 128 59 135 322b
Gastrointestinal problems 109 46 136 291b
Atypical fracture concerns 101 48 131 280
Preference for natural supplements 120 32 115 277
Drug inefﬁcacy concerns 73 51 142 266b
Medication interaction concerns 67 23 142 232b
Difﬁculty remembering medication 29 11 139 179
a Cumulative represents the total number of persons who ranked each of the barriers as#1,#2 or#3.
b Endorsed by all participants who ranked 4 or more barriers equally.
Fig. 3. Tailoring of video segments for women in the intervention arm of the Activating Patients at Risk for OsteoPOroSis (APROPOS) Study. Individuals were assigned video
segments based on four mutually exclusive, hierarchical levels: Group I: Ranked barriers to osteoporosis treatment, Group II: Other barriers identiﬁed on the survey including a
physician recommended break from medications and/or 5 years treatment, or concerns about long term adverse effects as identiﬁed on the Patients’ Views about Osteoporosis
(osteo) and therapy scale, Group III: Readiness to behavior change based on the Weinstein Precaution Adoption Process Model (PAPM), or Group IV: Previous treatment history. ONJ,
osteonecrosis of the jaw.
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reviewed the materials online. The relatively large proportion of
women interacting with the intervention online is notable given
the older age of the U.S. women involved in this study. This may
reﬂect the increasing proportion of older adults who use the
internet as a source for health-related information [50]. To our
knowledge, this is the ﬁrst behavioral, theoryeinformed, patient-
tailored, multi-modal intervention aimed at increasing initiation
of osteoporosis therapy in a high fracture risk population.
Attention to bone health through initiation of osteoporosis
treatment after a fracture remains a signiﬁcant challenge despite
the availability of national clinical guidelines and quality measures
[51,52]. A recent systematic review of interventions designed to
improve osteoporosis medication initiation in patients with oste-
oporosis highlights that multifaceted interventions targeting high-
risk patients and their primary care providers through patient
educational material, physician notiﬁcation, and/or physician ed-
ucation may improve the management of osteoporosis [53].
Further, an associated meta-analysis pooling the results of six trials
showed a 20% absolute increased incidence of osteoporosis treat-
ment initiation and a 40% increase in either bone mineral density
testing and/or osteoporosis treatment initiation in high-risk pa-
tients following interventions aimed at patients and/or physicians
[53]. Community pharmacist-based interventions for primary non-
adherence to osteoporosis medications have shown some success
in the Netherlands, but there is no similar intervention program or
strategy in the US [54,55]. There exists an urgent need to develop
effective strategies to promote adoption of appropriate osteopo-
rosis treatment at the patient level and, therefore, we developed a
novel, tailored intervention in older women with prior fractures,
the populationmost at risk for subsequent fractures, and tested it in
a randomized controlled trial.
Tailored, interactive educational programs hold promise in
healthy life-style promotion (e.g., smoking cessation [56], nutrition
education [57], physical activity [58] etc.) and self-management in
chronic disease (e.g,. diabetes mellitus [59], cancer [60]). Tailoring
can increase the perceived relevance of a message by stimulating
attention, comprehension, self-referential thinking and the depth
Fig. 4. Proportion of participants interacting with the video program online by
contact information. Phone only, email only, phone & email indicate phone number,
email, or both provided on baseline survey, respectively. No email/phone indicates no
email or phone number was provided on the baseline survey. Warm handoff call
informed participant of reason for intervention materials, as well as attempted to
identify and address barriers to watching videos. Reminder package contained copy of
introductory letter detailing instructions on how to access video program online and
another DVD with individualized video intervention. * Timing of these materials varied
up to ~1week. þVaried based on when/if warm handoff call completed. IVR, interactive
voice-response [5].
Table 3
Adjusted (aOR) and unadjusted odds ratio (OR) (and 95% conﬁdence intervals) estimates of logging on the website within 60 days of intervention initiation.
Characteristic Category Number (%) Crude Adjustedb Adjustedc
OR 95% CI OR 95% CI OR 95% CI
Email No 81 (21.5%) ref
Yes 296 (78.5%) 6.57 (4.97, 8.68) 5.10 (3.56, 7.31) 6.07 (4.53, 8.14)
Phone No 105 (27.8%) ref
Yes 272 (72.2%) 1.40 (1.08, 1.81) 1.23 (0.86. 1.75)
Age, every 10y 0.66 (0.54, 0.74) 0.74 (0.60, 0.94) 0.82 (0.66, 0.95)
Race/ethnicity Not Caucasian 14 (3.7%) ref
Caucasian 363 (96.3%) 2.38 (1.33, 4.24) 1.67 (0.72, 3.85) 1.76 (0.95, 3.27)
Education Less than high school 3 (0.8%) ref
High school 41 (11.0%) 2.36 (0.70, 8.03) 1.17 (0.22, 6.30)
Some college or more 329 (88.2%) 5.79 (1.77, 18.91) 1.80 (0.35, 9.28)
Recruitment site Worcester, MA 63 (16.7%) ref
Birmingham, AL 44 (11.7%) 0.82 (0.53, 1.28) 0.71 (0.39, 1.32)
Cincinnati, OH 35 (9.3%) 0.97 (0.60, 1.55) 0.79 (0.43, 1.45)
Los Angeles, CA 46 (12.2%) 1.77 (1.11, 2.80) 1.47 (0.81, 2.65)
New York, NY 52 (13.8%) 1.37 (0.89, 2.12) 1.37 (0.78, 2.41)
Pittsburgh, PA 55 (14.6%) 1.18 (0.78, 1.80) 0.87 (0.49, 1.54)
Seattle, WA 82 (21.8%) 1.49 (1.01, 2.20) 1.17 (0.71, 1.95)
Concerned about osteoporosis No 133 (38.2%) ref
Yes 215 (61.8%) 1.21 (0.93, 1.56) 1.15 (0.82, 1.61)
Depression No 70 (19.4%) ref
Yes 290 (80.6%) 0.86 (0.64, 1.16) 0.66 (0.45, 0.98) 0.72 (0.51, 0.996)
Prior osteoporosis drug use No 264 (71.5%) ref
Yes 105 (28.5%) 1.54 (1.18, 2.00) 0.79 (0.55, 1.12)
Readiness to behavior changea Precontemplative 239 (74.2%) ref
Contemplative 83 (25.8%) 1.06 (0.79, 1.43) 0.96 (0.64, 1.44)
Health literacy Inadequate 22 (5.9%) ref
Adequate 350 (94.1%) 2.85 (1.79, 4.54) 1.58 (0.79, 3.18)
a Readiness to behavior change assessed using a modiﬁed form of the Weinstein Precaution Adoption Process Model (PAPM).
b Adjusted for all characteristics.
c Adjusted for age, email, race/ethnicity, depression.
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of message processing [61]. We tailored the health messages in our
study to race/ethnicity and the individual characteristics related to
health behavior with hopes of increasing the probability for ma-
terials to be considered [62]. Homophily (i.e. identiﬁcationwith the
storyteller) is a mechanism for social inﬂuence in online health
information communication [63]. Individuals are more likely to
adopt the advice offered through educational messages, such as
ours, when they perceive more homophily with the information
stimulus [63] In a controlled experimental study on the spread of a
health innovation through ﬁxed social networks, in which homo-
phily was independently varied, homophily increased overall
adoption of a new health behavior, especially among those most in
need of it [64].
Efforts to promote initiation of osteoporosis medication need to
expand outside the infrequent face-to-face clinical encounters
focused on bone health. The internet represents an alternative
venue where online educational materials are convenient, easily
accessible, under the learners’ control, and overcome time and
mobility constraints, have the ability to reach a large number of
people and are less costly, scalable and reusable [36,65]. Our
educational intervention promoting osteoporosis therapy and uti-
lizing risk communication principles [66e68] was implemented via
the internet. In addition to asynchronous learning depending on
the participants’ schedule, thosewho engagedwithmaterials in the
online environment could review the educational content as many
times as they deemed necessary. Because an estimated 59% of
adults aged 65 and older use the internet [69], online interventions
may reach a substantial proportion of the geriatric population at
risk for future fracture, as evidenced by our ﬁndings. In one study,
older adult exposure to an 8-week theory-based program entitled
Bone Power that included learningmodules, discussion boards, and
other resources resulted in greater improvement in osteoporosis
knowledge, self-efﬁcacy/outcome expectations for calcium intake
and exercise behaviors compared to the group of adults who were
not exposed [70]. In our past experience, a direct-to-patient,
internet-based educational video intervention produced a trend
toward greater use of osteoporosis medication among patients
taking chronic glucocorticoids when the patients self-initiated an
educational video on osteoporosis prevention [71]. This suggests
that in order to change behavior and ultimately increase osteopo-
rosis medication use, patients need to actively engage with
educational interventions.
The delivery strategy of health messages inﬂuences the effec-
tiveness of health educational programs. Compared with written
messages, audiovisual messages, consonant with our approach,
increase recall of information in older adults [72]. Video-based
educational materials employing storytelling by patient actors
such as those in our study are engaging and inﬂuential in pro-
moting behavioral interventions [73e75]. Narrative communica-
tion is the basic mode of human interaction and audiences may
view messages as more personal, realistic, believable, and memo-
rable compared to didactic forms of communications [46]. Story-
telling promoted social support, decreased participants’ sense of
isolation, relieved stress, boosted self-conﬁdence and motivated
behavior change in African Americans with diabetes [76]. A
narrative video on use of mammography and cancer-related beliefs
in African American women was better liked, enhanced recall,
reduced counter-arguing, increased breast cancer discussions with
family members, and was perceived as more novel than an infor-
mational video [75]. Despite the positive effects of storytelling on
promotion of behavior change in some populations [75,76], our
team’s previous experience using a narrative communication
intervention did not increase appropriate BMD testing and
osteoporosis treatment in the targeted population beyond a
simpler intervention allowing self-scheduling, thus indicating the
need for further testing of this approach in osteoporosis [24].
We utilized reminder messages through phone calls and IVR in
an effort to increase participant engagement with the video inter-
vention. An IVR call and follow-up letter highlighting the beneﬁts
and risks of bisphosphonates increased two-fold the initiation of
bisphosphonate therapy in older women with osteoporosis
receiving care in a managed care setting [77]. However, we found
that despite a ~40e60% success rate in reaching the participants
through IVR and phone calls, which occurred when participants did
not logon to the interventionwebsite, these reminders did not have
an incremental beneﬁt in inﬂuencing the participants to access
their personalized videos online. In fact, those participants who
were contacted through warm handoff and IVR were signiﬁcantly
less likely to interact with their web educational program. A
possible explanation could be that the individuals we reached by
phone and who were effectively exposed to warm handoff and IVR,
were systematically different than those who logged on early or
who we could not successfully contact by phone. Alternatively, the
participants who were contacted via the warm handoff procedure
by the study personnel may have decided that they did not need or
want the osteoporosis education provided on their personalized
website and chose not to logon online to view the intervention
materials.
Our intervention design has some limitations. We strived to
design a highly tailored intervention responsive to individual bar-
riers to osteoporosis treatment that also accounted for an in-
dividual’s readiness to behavior change. However, not all barriers
were considered modiﬁable, some participants failed to list treat-
ment barriers, and others ranked several barriers as equally
important. We did not incorporate a conjoint analysis or alternative
approach to extricate participants’ speciﬁc reasoning and rankings.
Thus, we had difﬁculty providing an intervention individually
tailored on each and every component of participant-provided data
as envisioned, which may impact the overall effectiveness of our
intervention. Further, it remains unclear what the most important
elements are for optimal tailoring. For example, while for some
individuals tailoring on race/ethnicity may be important, for others
it may be less critical. Finally, the choice of the behavioral model
governing our intervention development may be questioned. There
are many behavioral theories addressing behavior change and ev-
idence implementation; we chose to model our intervention
development on the IMB model, which has been extensively used
in studies of HIV medication adherence [32].
In summary, we developed and successfully implemented a
tailored, multi-modal patient-directed intervention promoting
initiation or re-initiation of osteoporosis medications in women at
high risk of future fracture. Womenwho provided an email address
were considerably more likely to interact with our intervention
online. If our educational intervention proves effective at increasing
osteoporosis treatment rates, similar web-based interventions
aimed at individuals who obtain their health information online
have the potential to address osteoporosis treatment barriers and
our novel approach may be applicable to other chronic diseases.
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